time 0 is pretreatment time 3, 6 , 9, 12 months from the end of chemotherapy

Detailed Description:

our objective is to prospectively follow patients before and after their cancer treatment. this should help us learn of the gonadotoxicity of various treatments as well as be able to better consult these and future patients of the need of fertility preservation techniques.

Eligibility

Ages Eligible for Study:

5 Years to 45 Years (Child, Adult)

Sexes Eligible for Study:

Female

Accepts Healthy Volunteers:

No

Sampling Method:

Non-Probability Sample

Study Population

females 5-45 years old

Criteria

Inclusion Criteria:

all females prior and after chemotherapy

Exclusion Criteria:

do not consent

Contacts and Locations

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study.
To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below.
For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00930501